Advanced search
Publication Cover
Expert Opinion on Medical Diagnostics Volume 2, 2008 - Issue 6
Journal homepage
27
Views
0
CrossRef citations to date
0
Altmetric
Review

Nanotechnology in the diagnosis of atherosclerotic disease

Todd N Erpelding Philips Research North America, 345 Scarborough Road, Briarcliff Manor, NY 10510, USA [email protected]
, PhD,
Shelton D Caruthers Philips Healthcare, Andover, MA 01810, USA; Washington University, Department of Biomedical Engineering, St Louis, MO 63110, USA
, PhD,
Samuel A Wickline Washington University, Department of Biomedical Engineering, St Louis, MO 63110, USA; Washington University, Department of Medicine, St Louis, MO 63110, USA
, MD &
Gregory M Lanza Washington University, Department of Biomedical Engineering, St Louis, MO 63110, USA; Washington University, Department of Medicine, St Louis, MO 63110, USA
, MD, PhD
Pages 635-649 | Published online: 04 Jun 2008

Bibliography

  • Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics – 2007 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation 2007;115(5):e69-171
  • Libby P. Inflammation in atherosclerosis. Nature 2002;420(6917):868-74
  • Ambrose JA, Fuster V. The risk of coronary occlusion is not proportional to the prior severity of coronary stenoses. Heart 1998;79(1):3-4
  • Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 2003;108(14):1664-72
  • Virmani R, Kolodgie FD, Burke AP, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005;25(10):2054-61
  • Kolodgie FD, Gold HK, Burke AP, et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003;349(24):2316-25
  • Wickline SA, Neubauer AM, Winter PM, et al. Molecular imaging and therapy of atherosclerosis with targeted nanoparticles. J Magn Reson Imaging 2007;25(4):667-80
  • Josephson L, Kircher MF, Mahmood U, et al. Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. Bioconjug Chem 2002;13(3):554-60
  • Kelly KA, Allport JR, Tsourkas A, et al. Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ Res 2005;96(3):327-36
  • Winter PM, Neubauer AM, Caruthers SD, et al. Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. Arterioscler Thromb Vasc Biol 2006;26(9):2103-9
  • Jaffer FA, Libby P, Weissleder R. Molecular and cellular imaging of atherosclerosis: emerging applications. J Am Coll Cardiol 2006;47(7):1328-38
  • Jaffer FA, Libby P, Weissleder R. Molecular imaging of cardiovascular disease. Circulation 2007;116(9):1052-61
  • Geng YJ, Libby P. Evidence for apoptosis in advanced human atheroma. colocalization with interleukin-1 beta-converting enzyme. Am J Pathol 1995;147(2):251-66
  • Clarke MCH, Figg N, Maguire JJ, et al. Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 2006;12(9):1075-80
  • Jain KK. Nanodiagnostics: application of nanotechnology in molecular diagnostics. Expert Rev Mol Diagn 2003;3(2):153-61
  • Jain KK. Applications of nanobiotechnology in clinical diagnostics. Clin Chem 2007;53(11):2002-9
  • Fortina P, Kricka LJ, Surrey S, Grodzinski P. Nanobiotechnology: the promise and reality of new approaches to molecular recognition. Trends Biotechnol 2005;23(4):168-73
  • Cheng MM, Cuda G, Bunimovich YL, et al. Nanotechnologies for biomolecular detection and medical diagnostics. Curr Opin Chem Biol 2006;10(1):11-9
  • Craighead H. Future lab-on-a-chip technologies for interrogating individual molecules. Nature 2006;442(7101):387-93
  • Cunningham CH, Arai T, Yang PC, et al. Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles. Magn Reson Med 2005;53(5):999-1005
  • Stuber M, Gilson WD, Schär M, et al. Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with on-resonant water suppression (IRON). Magn Reson Med 2007;58(5):1072-7
  • Seppenwoolde J, Viergever MA, Bakker CJG. Passive tracking exploiting local signal conservation: the white marker phenomenon. Magn Reson Med 2003;50(4):784-90
  • Mani V, Briley-Saebo KC, Itskovich VV, et al. Gradient echo acquisition for superparamagnetic particles with positive contrast (GRASP): sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T. Magn Reson Med 2006;55(1):126-35
  • Liu W, Dahnke H, Jordan EK, et al. In vivo MRI using positive-contrast techniques in detection of cells labeled with superparamagnetic iron oxide nanoparticles. NMR Biomed 2008;21(3):242-50
  • Saini S, Stark DD, Hahn PF, et al. Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system. Radiology 1987;162(1 Pt 1):211-6
  • Saini S, Stark DD, Hahn PF, et al. Ferrite particles: a superparamagnetic MR contrast agent for enhanced detection of liver carcinoma. Radiology 1987;162(1 Pt 1):217-22
  • Schmitz SA, Coupland SE, Gust R, et al. Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits. Invest Radiol 2000;35(8):460-71
  • Ruehm SG, Corot C, Vogt P, et al. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001;103(3):415-22
  • Trivedi RA, U-King-Im J, Graves MJ, et al. In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke 2004;35(7):1631-5
  • Kooi ME, Cappendijk VC, Cleutjens KBJM, et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003;107(19):2453-8
  • Trivedi RA, Mallawarachi C, U-King-Im J, et al. Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler Thromb Vasc Biol 2006;26(7):1601-6
  • Tang TY, Howarth SPS, Li ZY, et al. Correlation of carotid atheromatous plaque inflammation with biomechanical stress: utility of USPIO enhanced MR imaging and finite element analysis. Atherosclerosis 2008;196(2):879-87
  • Tang TY, Howarth SPS, Miller SR, et al. Comparison of the inflammatory burden of truly asymptomatic carotid atheroma with atherosclerotic plaques contralateral to symptomatic carotid stenosis: an ultrasmall superparamagnetic iron oxide enhanced magnetic resonance study. J Neurol Neurosurg Psychiatry 2007;78:1337-43
  • Tang T, Howarth SPS, Miller SR, et al. Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke 2006;37(9):2266-70
  • Schellenberger EA, Bogdanov AJ, Högemann D, et al. Annexin v-CLIO: a nanoparticle for detecting apoptosis by MRI. Mol Imaging 2002;1(2):102-7
  • Smith BR, Heverhagen J, Knopp M, et al. Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONS) contrast particles for magnetic resonance imaging (MRI). Biomed Microdevices 2007;9(5):719-27
  • Sosnovik DE, Schellenberger EA, Nahrendorf M, et al. Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn Reson Med 2005;54(3):718-24
  • Gleich B, Weizenecker J. Tomographic imaging using the nonlinear response of magnetic particles. Nature 2005;435(7046):1214-7
  • Weizenecker J, Borgert J, Gleich B. A simulation study on the resolution and sensitivity of magnetic particle imaging. Phys Med Biol 2007;52(21):6363-74
  • Mattrey RF, Scheible FW, Gosink BB, et al. Perfluoroctylbromide: a liver/spleen-specific and tumor-imaging ultrasound contrast material. Radiology 1982;145(3):759-62
  • Mattrey RF, Long DM, Multer F, et al. Perfluoroctylbromide: a reticuloendothelial-specific and tumor-imaging agent for computed tomography. Radiology 1982;145(3):755-8
  • Mattrey RF, Hajek PC, Gylys-Morin VM, et al. Perfluorochemicals as gastrointestinal contrast agents for mr imaging: preliminary studies in rats and humans. AJR Am J Roentgenol 1987;148(6):1259-63
  • Flacke S, Fischer S, Scott MJ, et al. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation 2001;104(11):1280-5
  • Yu X, Song SK, Chen J, et al. High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn Reson Med 2000;44(6):867-72
  • Winter PM, Caruthers SD, Yu X, et al. Improved molecular imaging contrast agent for detection of human thrombus. Magn Reson Med 2003;50(2):411-6
  • Lanza GM, Lorenz CH, Fischer SE, et al. Enhanced detection of thrombi with a novel fibrin-targeted magnetic resonance imaging agent. Acad Radiol 1998;5(Suppl 1):S173-6; discussion S183-4
  • Winter PM, Cai K, Chen J, et al. Targeted paracest nanoparticle contrast agent for the detection of fibrin. Magn Reson Med 2006;56(6):1384-8
  • Anderson SA, Rader RK, Westlin WF, et al. Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles. Magn Reson Med 2000;44(3):433-9
  • Winter PM, Morawski AM, Caruthers SD, et al. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation 2003;108(18):2270-4
  • Caruthers SD, Neubauer AM, Hockett FD, et al. in vitro demonstration using 19F magnetic resonance to augment molecular imaging with paramagnetic perfluorocarbon nanoparticles at 1.5 Tesla. Invest Radiol 2006;41(3):305-12
  • Morawski AM, Winter PM, Yu X, et al. Quantitative “magnetic resonance immunohistochemistry” with ligand-targeted (19)F nanoparticles. Magn Reson Med 2004;52(6):1255-62
  • Neubauer AM, Caruthers SD, Hockett FD, et al. Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents. J Cardiovasc Magn Reson 2007;9(3):565-73
  • Frias JC, Williams KJ, Fisher EA, Fayad ZA. Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. J Am Chem Soc 2004;126(50):16316-7
  • Frias JC, Ma Y, Williams KJ, et al. Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imaging. Nano Lett 2006;6(10):2220-4
  • Lipinski MJ, Amirbekian V, Frias JC, et al. MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor. Magn Reson Med 2006;56(3):601-10
  • Li H, Gray BD, Corbin I, et al. MR and fluorescent imaging of low-density lipoprotein receptors. Acad Radiol 2004;11(11):1251-9
  • Corbin IR, Li H, Chen J, et al. Low-density lipoprotein nanoparticles as magnetic resonance imaging contrast agents. Neoplasia 2006;8(6):488-98
  • Amirbekian V, Lipinski MJ, Briley-Saebo KC, et al. Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc Natl Acad Sci USA 2007;104(3):961-6
  • Barkhausen J, Ebert W, Heyer C, et al. Detection of atherosclerotic plaque with gadofluorine-enhanced magnetic resonance imaging. Circulation 2003;108(5):605-9
  • Sirol M, Itskovich VV, Mani V, et al. Lipid-rich atherosclerotic plaques detected by gadofluorine-enhanced in vivo magnetic resonance imaging. Circulation 2004;109(23):2890-6
  • Koktzoglou I, Harris KR, Tang R, et al. Gadofluorine-enhanced magnetic resonance imaging of carotid atherosclerosis in Yucatan miniswine. Invest Radiol 2006;41(3):299-304
  • Meding J, Urich M, Licha K, et al. Magnetic resonance imaging of atherosclerosis by targeting extracellular matrix deposition with gadofluorine m. Contrast Media Mol Imaging 2007;2(3):120-9
  • Tomalia DA, Reyna LA, Svenson S. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. Biochem Soc Trans 2007;35(Pt 1):61-7
  • Kobayashi H, Brechbiel MW. Nano-sized MRI contrast agents with dendrimer cores. Adv Drug Deliv Rev 2005;57(15):2271-86
  • Langereis S, de Lussanet QG, van Genderen MHP, et al. Evaluation of Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging. NMR Biomed 2006;19(1):133-41
  • Prinzen L, Miserus RJHM, Dirksen A, et al. Optical and magnetic resonance imaging of cell death and platelet activation using annexin a5-functionalized quantum dots. Nano Lett 2007;7(1):93-100
  • Mulder WJM, Koole R, Brandwijk RJ, et al. Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. Nano Lett 2006;6(1):1-6
  • van Tilborg GAF, Mulder WJM, Chin PTK, et al. Annexin a5-conjugated quantum dots with a paramagnetic lipidic coating for the multimodal detection of apoptotic cells. Bioconjug Chem 2006;17(4):865-8
  • Botnar RM, Buecker A, Wiethoff AJ, et al. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent. Circulation 2004;110(11):1463-6
  • Spuentrup E, Buecker A, Katoh M, et al. Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent. Circulation 2005;111(11):1377-82
  • Botnar RM, Perez AS, Witte S, et al. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation 2004;109(16):2023-9
  • Spuentrup E, Katoh M, Buecker A, et al. Molecular MR imaging of human thrombi in a swine model of pulmonary embolism using a fibrin-specific contrast agent. Invest Radiol 2007;42(8):586-95
  • Sirol M, Aguinaldo JGS, Graham PB, et al. Fibrin-targeted contrast agent for improvement of in vivo acute thrombus detection with magnetic resonance imaging. Atherosclerosis 2005;182(1):79-85
  • Sirol M, Fuster V, Badimon JJ, et al. Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent. Circulation 2005;112(11):1594-600
  • Spuentrup E, Fausten B, Kinzel S, et al. Molecular magnetic resonance imaging of atrial clots in a swine model. Circulation 2005;112(3):396-9
  • Sipkins DA, Cheresh DA, Kazemi MR, et al. Detection of tumor angiogenesis in vivo by alphavbeta3-targeted magnetic resonance imaging. Nat Med 1998;4(5):623-6
  • Kabalka GW, Buonocore E, Hubner K, et al. Gadolinium-labeled liposomes containing paramagnetic amphipathic agents: targeted MRI contrast agents for the liver. Magn Reson Med 1988;8(1):89-95
  • Unger E, Needleman P, Cullis P, Tilcock C. Gadolinium-DTPA liposomes as a potential MRI contrast agent. Work in progress. Invest Radiol 1988;23(12):928-32
  • Mulder WJM, Strijkers GJ, Griffioen AW, et al. A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets. Bioconjug Chem 2004;15(4):799-806
  • Mulder WJM, Douma K, Koning GA, et al. Liposome-enhanced MRI of neointimal lesions in the ApoE-KO mouse. Magn Reson Med 2006;55(5):1170-4
  • Rossin R, Pan D, Qi K, et al. 64cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation. J Nucl Med 2005;46(7):1210-8
  • Pressly ED, Rossin R, Hagooly A, et al. Structural effects on the biodistribution and positron emission tomography (PET) imaging of well-defined (64)Cu-labeled nanoparticles comprised of amphiphilic block graft copolymers. Biomacromolecules 2007;8(10):3126-34
  • Hu G, Lijowski M, Zhang H, et al. Imaging of VX-2 rabbit tumors with alpha(nu)beta3-integrin-targeted 111In nanoparticles. Int J Cancer 2007;120(9):1951-7
  • Mitra A, Nan A, Line BR, Ghandehari H. Nanocarriers for nuclear imaging and radiotherapy of cancer. Curr Pharm Des 2006;12(36):4729-49
  • Nahrendorf M, Zhang H, Hembrador S, et al. Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation 2008;117(3):379-87
  • Davies JR, Rudd JHF, Weissberg PL, Narula J. Radionuclide imaging for the detection of inflammation in vulnerable plaques. J Am Coll Cardiol 2006;47(8 Suppl):C57-68
  • Rudd JHF, Warburton EA, Fryer TD, et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002;105(23):2708-11
  • Davies JR, Rudd JHF, Fryer TD, et al. Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke 2005;36(12):2642-7
  • Tahara N, Kai H, Yamagishi S, et al. Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol 2007;49(14):1533-9
  • Tahara N, Kai H, Nakaura H, et al. The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose positron emission tomography. Eur Heart J 2007;28(18):2243-8
  • Rudd JHF, Myers KS, Bansilal S, et al. (18)fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol 2007;50(9):892-6
  • Kopka K, Breyholz H, Wagner S, et al. Synthesis and preliminary biological evaluation of new radioiodinated MMP inhibitors for imaging MMP activity in vivo. Nucl Med Biol 2004;31(2):257-67
  • Schäfers M, Riemann B, Kopka K, et al. Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo. Circulation 2004;109(21):2554-9
  • Breyholz HJ, Wagner S, Levkau B, Schober O, et al. A 18F-radiolabeled analogue of CGS 27023a as a potential agent for assessment of matrix-metalloproteinase activity in vivo. Q J Nucl Med Mol Imaging 2007;51(1):24-32
  • Kietselaer BLJH, Reutelingsperger CPM, Heidendal GAK, et al. Noninvasive detection of plaque instability with use of radiolabeled annexin a5 in patients with carotid-artery atherosclerosis. N Engl J Med 2004;350(14):1472-3
  • Kolodgie FD, Petrov A, Virmani R, et al. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin v: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation 2003;108(25):3134-9
  • Iuliano L, Signore A, Vallabajosula S, et al. Preparation and biodistribution of 99m technetium labelled oxidized LDL in man. Atherosclerosis 1996;126(1):131-41
  • Shaish A, Keren G, Chouraqui P, et al. Imaging of aortic atherosclerotic lesions by (125)I-LDL, (125)I-oxidized-LDL, (125)I-HDL and (125)I-BSA. Pathobiology 2001;69(4):225-9
  • Bozóky Z, Balogh L, Máthé D, et al. Preparation and investigation of 99m technetium-labeled low-density lipoproteins in rabbits with experimentally induced hypercholesterolemia. Eur Biophys J 2004;33(2):140-5
  • Shaw PX, Hörkkö S, Tsimikas S, et al. Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo. Arterioscler Thromb Vasc Biol 2001;21(8):1333-9
  • Torzewski M, Shaw PX, Han K, et al. Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization. Arterioscler Thromb Vasc Biol 2004;24(12):2307-12
  • Tsimikas S, Palinski W, Halpern SE, et al. Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, dentifies native atherosclerotic lesions in vivo. J Nucl Cardiol 1999;6(1 Pt 1):41-53
  • Unger EC, McCreery TP, Sweitzer RH, et al. in vitro studies of a new thrombus-specific ultrasound contrast agent. Am J Cardiol 1998;81(12A):G58-61
  • Villanueva FS, Wagner WR, Vannan MA, Narula J. Targeted ultrasound imaging using microbubbles. Cardiol Clin 2004;22(2):283-98
  • Lindner JR. Molecular imaging with contrast ultrasound and targeted microbubbles. J Nucl Cardiol 2004;11(2):215-21
  • Dayton PA, Ferrara KW. Targeted imaging using ultrasound. J Magn Reson Imaging 2002;16(4):362-77
  • Kaufmann BA, Lindner JR. Molecular imaging with targeted contrast ultrasound. Curr Opin Biotechnol 2007;18(1):11-6
  • Dayton PA, Pearson D, Clark J, et al. Ultrasonic analysis of peptide- and antibody-targeted microbubble contrast agents for molecular imaging of alphavbeta3-expressing cells. Mol Imaging 2004;3(2):125-34
  • Ellegala DB, Leong-Poi H, Carpenter JE, et al. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. Circulation 2003;108(3):336-41
  • Villanueva FS, Jankowski RJ, Klibanov S, et al. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation 1998;98(1):1-5
  • Kaufmann BA, Sanders JM, Davis C, et al. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation 2007;116(3):276-84
  • Lanza GM, Wallace KD, Scott MJ, et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 1996;94(12):3334-40
  • Lanza GM, Wallace KD, Fischer SE, et al. High-frequency ultrasonic detection of thrombi with a targeted contrast system. Ultrasound Med Biol 1997;23(6):863-70
  • Lanza GM, Abendschein DR, Hall CS, et al. In vivo molecular imaging of stretch-induced tissue factor in carotid arteries with ligand-targeted nanoparticles. J Am Soc Echocardiogr 2000;13(6):608-14
  • Lanza GM, Trousil RL, Wallace KD, et al. in vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy. J Acoust Soc Am 1998;104(6):3665-72
  • Marsh JN, Hall CS, Scott MJ, et al. Improvements in the ultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line model. IEEE Trans Ultrason Ferroelectr Freq Control 2002;49(1):29-38
  • Hall CS, Lanza GM, Rose JH, et al. Experimental determination of phase velocity of perfluorocarbons: applications to targeted contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control 2000;47(1):75-84
  • Hughes MS, McCarthy JE, Marsh JN, et al. Properties of an entropy-based signal receiver with an application to ultrasonic molecular imaging. J Acoust Soc Am 2007;121(6):3542-57
  • Huang S, Hamilton AJ, Pozharski E, et al. Physical correlates of the ultrasonic reflectivity of lipid dispersions suitable as diagnostic contrast agents. Ultrasound Med Biol 2002;28(3):339-48
  • Coussios C, Holland CK, Jakubowska L, et al. in vitro characterization of liposomes and optison by acoustic scattering at 3.5 MHz. Ultrasound Med Biol 2004;30(2):181-90
  • Hamilton AJ, Huang S, Warnick D, et al. Intravascular ultrasound molecular imaging of atheroma components in vivo. J Am Coll Cardiol 2004;43(3):453-60
  • Hamilton A, Huang S, Warnick D, et al. Left ventricular thrombus enhancement after intravenous injection of echogenic immunoliposomes: studies in a new experimental model. Circulation 2002;105(23):2772-8
  • Buchanan KD, Huang S, Kim H, et al. Echogenic liposome compositions for increased retention of ultrasound reflectivity at physiologic temperature. J Pharm Sci 2008;97(6):2242-9
  • Tiukinhoy-Laing SD, Huang S, Klegerman M, et al. Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes. Thromb Res 2007;119(6):777-84
  • Budoff MJ, Achenbach S, Blumenthal RS, et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association committee on cardiovascular imaging and intervention, council on cardiovascular radiology and intervention, and committee on cardiac imaging, council on clinical cardiology. Circulation 2006;114(16):1761-91
  • Naghavi M, Falk E, Hecht HS, et al. From vulnerable plaque to vulnerable patient – part III: executive summary of the screening for heart attack prevention and education (SHAPE) task force report. Am J Cardiol 2006;98(2A):H2-15
  • Winter PM, Shukla HP, Caruthers SD, et al. Molecular imaging of human thrombus with computed tomography. Acad Radiol 2005;12(Suppl 1):S9-13
  • Hyafil F, Cornily J, Feig JE, et al. Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med 2007;13(5):636-41
  • Fayad ZA, Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res 2001;89(4):305-16
  • Fagan JA, Simpson JR, Bauer BJ, et al. Length-dependent optical effects in single-wall carbon nanotubes. J Am Chem Soc 2007;129(34):10607-12
  • Tsyboulski DA, Rocha JR, Bachilo SM, et al. Structure-dependent fluorescence efficiencies of individual single-walled carbon nanotubes. Nano Lett 2007;7(10):3080-5
  • Choi JH, Nguyen FT, Barone PW, et al. Multimodal biomedical imaging with asymmetric single-walled carbon nanotube/iron oxide nanoparticle complexes. Nano Lett 2007;7(4):861-7
  • Hirsch LR, Stafford RJ, Bankson JA, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA 2003;100(23):13549-54
  • Loo C, Lin A, Hirsch L, et al. Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol Cancer Res Treat 2004;3(1):33-40
  • O'Neal DP, Hirsch LR, Halas NJ, et al. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett 2004;209(2):171-6
  • El-Sayed IH, Huang X, El-Sayed MA. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett 2006;239(1):129-35
  • Huang X, El-Sayed IH, Qian W, El-Sayed MA. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 2006;128(6):2115-20
  • Huff TB, Tong L, Zhao Y, et al. Hyperthermic effects of gold nanorods on tumor cells. Nanomedicine 2007;2(1):125-32
  • Yu C, Irudayaraj J. Multiplex biosensor using gold nanorods. Anal Chem 2007;79(2):572-9
  • Oyelere AK, Chen PC, Huang X, et al. Peptide-conjugated gold nanorods for nuclear targeting. Bioconjug Chem 2007;18(5):1490-7
  • Huang X, Jain PK, El-Sayed IH, El-Sayed MA. Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine 2007;2(5):681-93
  • Copland JA, Eghtedari M, Popov VL, et al. Bioconjugated gold nanoparticles as a molecular based contrast agent: implications for imaging of deep tumors using optoacoustic tomography. Mol Imaging Biol 2004;6(5):341-9
  • Li P, Wei C, Liao C, et al. Photoacoustic imaging of multiple targets using gold nanorods. IEEE Trans Ultrason Ferroelectr Freq Control 2007;54(8):1642-7
  • Kim G, Huang S, Day KC, et al. Indocyanine-green-embedded pebbles as a contrast agent for photoacoustic imaging. J Biomed Opt 2007;12(4):044020
  • Akerman ME, Chan WCW, Laakkonen P, et al. Nanocrystal targeting in vivo. Proc Natl Acad Sci USA 2002;99(20):12617-21
  • Gao X, Cui Y, Levenson RM, et al. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004;22(8):969-76
  • Michalet X, Pinaud FF, Bentolila LA, et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005;307(5709):538-44
  • Pisanic TR2, Blackwell JD, Shubayev VI, et al. Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials 2007;28(16):2572-81
  • Ersoy H, Rybicki FJ. Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis. J Magn Reson Imaging 2007;26(5):1190-7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.